Cargando…

Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes

End-stage kidney disease (ESKD) is a multifactorial condition influenced by genetic background, but the extent to which a genetic risk score (GRS) improves ESKD prediction is unknown. We built a redox GRS on the base of previous association studies (six polymorphisms from six redox genes) and tested...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammedi, Kamel, Marre, Michel, Hadjadj, Samy, Potier, Louis, Velho, Gilberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777489/ https://www.ncbi.nlm.nih.gov/pubmed/36552894 http://dx.doi.org/10.3390/cells11244131

Ejemplares similares

Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018)

Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
por: Sanchez, Manuel, et al.
Publicado: (2022)

Manganese Superoxide Dismutase (SOD2) Polymorphisms, Plasma Advanced Oxidation Protein Products (AOPP) Concentration and Risk of Kidney Complications in Subjects with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013)

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
por: Camoin, Marion, et al.
Publicado: (2022)

SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)

Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2015)

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review
por: Nativel, Mathilde, et al.
Publicado: (2018)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus
por: Potier, Louis, et al.
Publicado: (2018)

Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population
por: Petria, Iulia, et al.
Publicado: (2022)

The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rational
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor
por: Mohammedi, Kamel, et al.
Publicado: (2014)

Eosinophilia and risk of incident end stage kidney disease
por: Tariq, Anam, et al.
Publicado: (2020)

Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease
por: Sekula, Peggy, et al.
Publicado: (2020)

Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion
por: Gautier, Jean-François, et al.
Publicado: (2018)

Comparison of a new versus standard removable offloading device in patients with neuropathic diabetic foot ulcers: a French national, multicentre, open-label randomized, controlled trial
por: Potier, Louis, et al.
Publicado: (2020)

Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes
por: Schneider, Fabrice, et al.
Publicado: (2018)

Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
por: Lee, Min-Jeong, et al.
Publicado: (2020)

Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO Study
por: Wargny, Matthieu, et al.
Publicado: (2020)

End-stage kidney disease among indigenous peoples of Australia and New Zealand
por: McDonald, Stephen P
Publicado: (2013)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Nationwide Glaucoma incidence in end stage renal disease patients and kidney transplant recipients
por: Moon, Jong Joo, et al.
Publicado: (2021)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

Increased serum S100A12 levels are associated with higher risk of acute heart failure in patients with type 2 diabetes
por: Gellen, Barnabas, et al.
Publicado: (2022)

End of Life Care in End-Stage Kidney Disease
por: Prabhu, Ravindra Attur, et al.
Publicado: (2021)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021)

Value of multilocus genetic risk score for atrial fibrillation in end-stage kidney disease patients in a Polish population
por: Saracyn, Marek, et al.
Publicado: (2018)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018)

Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963–2014)
por: Fernando, Mangalee R., et al.
Publicado: (2017)

Kidney Cancer Incidence in California: End of the Trend?
por: Morris, Cyllene R., et al.
Publicado: (2017)

The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis
por: Chang, Wen Xiu, et al.
Publicado: (2016)

Associations of kidney tests at medical facilities and health checkups with incidence of end-stage kidney disease: a retrospective cohort study
por: Yoshimura, Ryuichi, et al.
Publicado: (2021)

Impact of Natriuretic Peptide Clearance Receptor (NPR3) Gene Variants on Blood Pressure in Type 2 Diabetes
por: Saulnier, Pierre-Jean, et al.
Publicado: (2011)

Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people
por: Kang, Shin Chan, et al.
Publicado: (2022)

Propensity Score-Matched Analysis of the Survival Benefit from Kidney Transplantation in Patients with End-Stage Renal Disease
por: Wu, Ming-Ju, et al.
Publicado: (2018)

Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies
por: Hadjadj, Samy, et al.
Publicado: (2008)

Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
por: González-Pérez, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_msd5mqnni4qv1p33j5cng5sh38